SYMPOSIUM INFORMATION
>General Information
>Faculty
>Program/Schedule
>Accreditation
>Registration
Sponsored by:
Biomarker Research Program
|

PROGRAM / SCHEDULE
All times are Pacific Standard Time (PST)
>Download Symposium Brochure
8:00-8:10 AM Introductions, Welcome and Program Overview
Drs. Alan Maisel and Lori Daniels
SESSION I: Acute Coronary Syndrome
Allan Jaffe, Moderator
8:10 – 8:30AM hsTn in the Evaluation of Patients
Frank Peacock, MD
8:30 – 9:00AM State of the Art Talk: Point of Care Troponin
Pedro Lopez Ayala, MD, MSc
9:00 – 9:20AM Biomarkers and Type 1 vs Type 2 MI
Hanna Gaggin, MD
9:20 9:50AM
Acute Coronary Syndrome Case Presentations/Panel
Drs. Lopez Ayala, Gaggin, Jaffe, Peacock, Daniels
9:50 10:15AM Break/Visit Exhibits
SESSION II: Biomarkers in Heart Failure
Alan Maisel, MD Moderator
10:15 10:30AM Biomarkers for Predicting, Managing and Guiding CVD
Lori Daniels, MD
10:30 10:45AM HFpEF Biomarkers
Rudolf deBoer, MD
10:45 11:00AM Recent Therapies in Heart Failure (Entresto, ivabradine, CCM, etc)
Eric Adler, MD
11:00 11:15AM Cardiologists and HbA1c: Novel Diabetes Drugs and the Cardiologist as Diabetician
Gregg Fonarow, MD
11:15 11:30AM Amyloid Cardiomyopathy: New Opportunities
Tony Urey, MD
11:30 12:00PM
Heart Failure Case Presentations and Panel
Drs. Maisel, Fonarow, Adler, Urey, deBoer, Wettersten, Daniels
12:00 1:00
Product Theatre
The Next Horizon in the Heart Failure Treatment Paradigm for Patients With HFrEF
Warren Fegenbush, PharmD, BCPS
SESSION III: Devices, COVID-19 and Personalized Medicine
Lori Daniels, MD, Moderator
1:05 – 1:20PM Wearable Devices and Apps for Heart Disease and Health
Jia Shen, MD
1:20 – 1:35PM Machine Learning and Biomarkers: A marriage made in heaven
Alan Maisel, MD
1:35 – 2:05PM SPECIAL LECTURE COVID-19 as a disease of the Endothelium
Tom Lόscher, MD
2:05 2:35PM SPECIAL LECTURE COVID-19 and Biomarkers for Prognosis and Guiding Treatment?
Torbjorn Omland, MD
2:35 – 2:55PM Lipid Biomarkers and Therapies
Pam Taub, MD
2:55 3:20PM Break/Visit Exhibits
SESSION IV: Biomarkers in Arrhythmias and Pulmonary Arterial Hypertension, and Devices
Alan Maisel, Moderator
3:20 3:35PM International Normalized Ratio (INR) as a Biomarker Anticoagulation and Reversal in AFib, Heart Failure and Cardiovascular Disease
Daniel Blanchard, MD
3:35 3:50PM INR as a Biomarker Part 2: Left Atrial Appendage Occlusion Devices for Doing Away with INR
Ryan Reeves, MD
3:50 4:05PM Biomarkers and Arrhythmias/Devices
David Krummen, MD
4:05 4:20PM Cardiomems: Incorporating a Pulmonary Artery Device and Biomarkers in Outpatients with Heart Failure
Howie Tran, MD
4:20 4:35PM Biomarkers and Treatment in Pulmonary Arterial Hypertension
Tim Fernandes, MD
4:35 4:50PM Potassium as a Treatable Biomarker in Cardiovascular Disease: New Keys to Hyperkalemia
Nicholas Wettersten, MD
4:50 – 4:55PM Concluding Remarks
Drs. Alan Maisel and Lori Daniels


|